Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
BMC Infectious Diseases|May 25, 2011
To use or not to use a condom: a prospective cohort study comparing contraceptive practices among HIV-infected and HIV-negative youth in UgandaJolly Beyeza-Kashesya, Frank Kaharuza, Anna Mia Ekström, et al.African Journal of Reproductive Health|August 11, 2010
"Not a boy, not a child": A qualitative study on young people's views on childbearing in UgandaJolly Beyeza-Kashesy, Stella Neema, Anna Mia Ekstrom, et al.BMC Public Health|May 15, 2010
My partner wants a child: a cross-sectional study of the determinants of the desire for children among mutually disclosed sero-discordant couples receiving care in UgandaJolly Beyeza-Kashesya, Anna Mia Ekstrom, Frank Kaharuza, et al.African Health Sciences|September 16, 2010
The dilemma of safe sex and having children: challenges facing HIV sero-discordant couples in UgandaJolly Beyeza-Kashesya, Frank Kaharuza, Florence Mirembe, et al.Reproductive Health|January 1, 2009
Adolescent and adult first time mothers' health seeking practices during pregnancy and early motherhood in Wakiso district, central UgandaLynn Atuyambe, Florence Mirembe, Nazarius M Tumwesigye, et al.Obstetrics and Gynecology|September 2, 2005
A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortionAndrew Weeks, Godfrey Alia, Jennifer Blum, et al.BMC Pregnancy and Childbirth|November 28, 2015
Effectiveness and safety of misoprostol distributed to antenatal women to prevent postpartum haemorrhage after child-births: a stepped-wedge cluster-randomized trialSam Ononge, Oona M R Campbell, Frank Kaharuza, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 3, 2013
Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, UgandaSam Ononge, Charles Karamagi, Clemensia Nakabiito, et al.Reproductive Health|March 4, 2017
Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trialSarah Nakubulwa, Dan K Kaye, Freddie Bwanga, et al.American Journal of Obstetrics and Gynecology|November 5, 2013
Pregnancy, parturition and preeclampsia in women of African ancestryAnnettee Nakimuli, Olympe Chazara, Josaphat Byamugisha, et al.Pageof 7